Table 2.

Expression of BCL2 protein and BCL2 mRNA in DLBCL subgroups of R-CHOP–treated patients

DLBCL subgroupsBCL2 positive, n (%)BCL2 negative, n (%)
BCL2 protein
ABC (n = 73)45 (62)28 (38)
GCB (n = 73)22 (30)51 (70)
Unclassifiable (n = 23)8 (35)15 (65)
BCL2 mRNA
DLBCL subgroupsMean intensity value (log2 scale), SD (range)
ABC (n = 88)9.11.3 (5.8–11.6)
GCB (n = 102)8.61.5 (4.8–11.8)
Unclassifiable (n = 31)8.70.9 (7.5–11.1)